Prosecution Insights
Last updated: April 19, 2026

Kindeva Drug Delivery L P

7 pending office actions

Portfolio Summary

7
Total Pending OAs
2
Final Rejections
5
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
18606272 FORMULATION AND AEROSOL CANISTERS, INHALERS, AND THE LIKE CONTAINING THE FORMULATION HAGHIGHATIAN, MINA 1616 Non-Final OA Mar 15, 2024
18599422 METERED DOSE INHALERS AND SUSPENSION COMPOSITIONS BOECKER, JOSEPH D 3785 Final Rejection Mar 08, 2024
18025491 APPARATUS FOR AGITATION OF MEDICAMENT FORMULATION DITMER, KATHRYN ELIZABETH 3785 Non-Final OA Mar 09, 2023
17802431 INHALER WOODWARD, VALERIE LYNN 3785 Non-Final OA Aug 25, 2022
17779028 CARBON DIOXIDE BASED METERED DOSE INHALER ZHANG, TINA 3785 Non-Final OA May 23, 2022
17624433 AEROSOL FORMULATION, CANISTER, AND INHALER CONTAINING THE FORMULATION, AND METHOD OF USE HAGHIGHATIAN, MINA 1616 Final Rejection Jan 03, 2022
17620325 AEROSOL FORMULATION, CANISTER, AND INHALER CONTAINING THE FORMULATION, AND METHOD OF USE LIU, SUE XU 1616 Non-Final OA Dec 17, 2021

Managing Kindeva Drug Delivery L P's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month